GlaxoSmithKline buys 10% of German vaccine maker
July 20, 2020 at 11:08 AM EDT
The companies plan to develop up to five infectious disease therapies, but a potential Covid-19 vaccine is not on the list.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|